In the BioHarmony Drug Report Database
Cholecalciferol
Fosamax Plus D (cholecalciferol) is a small molecule pharmaceutical. Cholecalciferol was first approved as Fosamax Plus D on 2005-04-07. It is used to treat cardiovascular diseases, chronic kidney failure, crohn disease, familial hypophosphatemic rickets, and hypoparathyroidism amongst others in the USA.
Trade Name
|
Fosamax Plus D |
|---|---|
Common Name
|
cholecalciferol |
ChEMBL ID
|
CHEMBL1042 |
Indication
|
cardiovascular diseases, chronic kidney failure, crohn disease, familial hypophosphatemic rickets, hypoparathyroidism, lung neoplasms, osteoporosis, psoriasis, skin neoplasms |
Drug Class
|
Vitamin D analogues |
Image (chem structure or protein)